{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380004239703084160.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Takeshi Oguchi"}],"foaf:familyName":[{"@value":"Oguchi"}],"foaf:givenName":[{"@value":"Takeshi"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360004239703084160","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.3899/jrheum.130901"},{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.3899/jrheum.130901"}],"notation":[{"@value":"Longterm Retention Rate and Risk Factor for Discontinuation Due to Insufficient Efficacy and Adverse Events in Japanese Patients with Rheumatoid Arthritis Receiving Etanercept Therapy"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3899/jrheum.130901_WObDm8wvExxWYLCzQYoUxga1WU8"},{"@type":"OPENAIRE","@value":"doi_dedup___::bdb39cc29e4c16b211bfad42e02a3275_WObDm8wvExxWYLCzQYoUxga1WU8"}]}